Swedbank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95M | Buy |
330,617
+104
| +0% | +$29.9K | 0.11% | 153 |
|
2025
Q1 | $102M | Sell |
330,513
-4,992
| -1% | -$1.54M | 0.14% | 133 |
|
2024
Q4 | $118M | Sell |
335,505
-79,432
| -19% | -$28M | 0.15% | 116 |
|
2024
Q3 | $149M | Sell |
414,937
-7,718
| -2% | -$2.77M | 0.19% | 106 |
|
2024
Q2 | $135M | Sell |
422,655
-975
| -0.2% | -$311K | 0.18% | 100 |
|
2024
Q1 | $97.3M | Buy |
423,630
+10,463
| +3% | +$2.4M | 0.85% | 5 |
|
2023
Q4 | $90.9M | Sell |
413,167
-4,780
| -1% | -$1.05M | 0.15% | 121 |
|
2023
Q3 | $94.4M | Buy |
417,947
+12,645
| +3% | +$2.86M | 0.16% | 109 |
|
2023
Q2 | $89.5M | Sell |
405,302
-2,779
| -0.7% | -$613K | 0.15% | 114 |
|
2023
Q1 | $91.4M | Sell |
408,081
-1,710
| -0.4% | -$383K | 0.18% | 108 |
|
2022
Q4 | $114M | Sell |
409,791
-2,784
| -0.7% | -$774K | 0.25% | 87 |
|
2022
Q3 | $86.4M | Hold |
412,575
| – | – | 0.21% | 98 |
|
2022
Q2 | $97.2M | Sell |
412,575
-6,643
| -2% | -$1.57M | 0.22% | 98 |
|
2022
Q1 | $75.2M | Buy |
419,218
+6,104
| +1% | +$1.1M | 0.14% | 141 |
|
2021
Q4 | $88.9M | Hold |
413,114
| – | – | 0.15% | 135 |
|
2021
Q3 | $76.3M | Hold |
413,114
| – | – | 0.14% | 138 |
|
2021
Q2 | $74.1M | Hold |
413,114
| – | – | 0.14% | 141 |
|
2021
Q1 | $69.1M | Buy |
+413,114
| New | +$69.1M | 0.14% | 146 |
|